Blog

Sharesight users' top 20 trades in ASX stocks for 2023

by Stephanie Stefanovic, Content Manager, Sharesight | Dec 20th 2023

Each year, Sharesight looks back at the top 20 buy and sell trades made by Sharesight users throughout the year. Welcome to the 2023 edition of our ASX snapshot, where we explore the top trades users have made in stocks on the ASX this year, plus the market-moving news behind some of these stocks.

Sharesight users’ top 20 ASX stocks traded in 2023

Top20 ASX trades 2023

This year’s top trades were largely dominated by blue chip stocks and Vanguard ETFs.

Buy trades were strongly led by Vanguard’s Australian Shares Index ETF (ASX: VAS), followed by the ETF provider’s MSCI Index International Shares ETF (ASX: VGS). In terms of individual stocks, buy trades were led by Pilbara Minerals (ASX: PLS), which saw its share price swing wildly throughout the year, ultimately ending the year up almost 5% (as at the time of publishing). Sell trades were led by Woodside Energy (ASX: WDS), which saw its share price peak in Q3, followed by a steep decline in Q4, ending the year down almost 12%.

It was a themed year overall, with Sharesight users likely flocking to bank stocks due to their increased profitability amid 2023’s rising rate environment. At the same time, many users were opportunistic, taking advantage of price dips in mining stocks throughout the year.

Let’s look at the news behind some of the key stocks in this year’s snapshot:

Pilbara Minerals (ASX: PLS)

BHP (ASX: BHP)

Woodside Energy (ASX: WDS)

CSL (ASX: CSL)

Macquarie Group (ASX: MQG)

Westpac (ASX: WBC)

  • January: Westpac share price up 20% in 6 months
  • February: Share price drops following mixed quarterly results
  • May: Westpac shares jump following announcement of AU$4 billion half-yearly profit
  • August: Announces AU$1.8 billion quarterly profit; 10% down from first-half quarterly average
  • September: ASIC sues Westpac over alleged failure on hardship notices; share price dips
  • November: Share price rises on strong earnings, big dividend and AU$1.5 billion share buyback

ResMed (ASX: RMD)

ANZ (ASX: ANZ)

Track your investment portfolio with Sharesight

Get access to Sharesight20 insights like this by tracking your investment portfolio with Sharesight. Built for the needs of investors like you:

Sign up for a FREE Sharesight account and get started tracking your investments today.

Disclaimer: This article is for informational purposes only and does not constitute a specific product recommendation, or taxation or financial advice and should not be relied upon as such. While we use reasonable endeavours to keep the information up-to-date, we make no representation that any information is accurate or up-to-date. If you choose to make use of the content in this article, you do so at your own risk. To the extent permitted by law, we do not assume any responsibility or liability arising from or connected with your use or reliance on the content on our site. Please check with your adviser or accountant to obtain the correct advice for your situation.

FURTHER READING

Timing the market with ETFs

You can time the market – and ETFs are the way to do it

by Marcus Padley | Apr 15th 2025

Marcus Today founder and director Marcus Padley discusses timing the market, and how investors can do this using exchange-traded funds (ETFs).

Morningstar analysis Q1 2025

Morningstar analyses Australian investors’ top trades: Q1 2025

by Mark LaMonica, Morningstar Director of Personal Finance | Apr 9th 2025

Morningstar reviews the top 20 trades by Australian Sharesight users in Q1 2025, and reveals where their analysts see potential opportunities.

Sharesight April product updates 2025

Sharesight product updates – April 2025

by Ben Clendon | Apr 8th 2025

This month's focus was on improving cash account syncing, revamping the future income report and enabling Apple login functionality.